Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Apatinib in Metastatic Esophageal Cancer：A Open Label, Randomized Clinical Trial

NCT02683655 is registered in ClinicalTrials.gov with Huai'an First People's Hospital as lead sponsor.

NCT NCT02683655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02683655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Apatinib in Metastatic Esophageal Cancer：A Open Label, Randomized Clinical Trial
Lead sponsor
Huai'an First People's Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2015
Completion date
Not reported
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer